
Calcium Dobesilate 1-hydrate by Zyntex is a high-purity pharmaceutical active ingredient (CAS 20123-80-2). It is a gold-standard vasoprotective agent used in the formulation of medications for diabetic retinopathy, chronic venous insufficiency, and microangiopathy.
In the field of vascular medicine and pharmaceutical engineering, the ability to stabilize capillary walls is a major advantage. Calcium Dobesilate 1-hydrate is specifically selected because it increases the resistance of the capillary vessels while inhibiting platelet aggregation. For instance, it is a critical component in chronic treatments for patients suffering from venous hypertension. Consequently, it facilitates the reduction of edema and improves overall microcirculation. As a result, Zyntex ensures that our Calcium Dobesilate 1-hydrate meets the most stringent EP and USP pharmacopeia standards to ensure maximum clinical safety.
Moreover, the pharmaceutical-grade Calcium Dobesilate 1-hydrate provided by Zyntex is a vital component in the management of diabetic retinopathy. This application allows for the prevention of vision loss by maintaining vascular integrity in the retina, undoubtedly pushing the boundaries of ophthalmic pharmacology. At the same time, its role in reducing blood viscosity is highly valued by cardiovascular researchers. In short, our product serves as a dependable “vascular stabilizer” for companies focusing on both chronic disease management and innovative drug development.
Recently, scientific interest has surged regarding the anti-inflammatory properties of dobesilate salts in dermatological applications. Because of this, Zyntex offers specialized bulk supply options to provide reliable consistency for global pharmaceutical supply chains. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances high-purity API production with rigorous analytical testing. To conclude, our commitment to excellence ensures that your manufacturing processes achieve the highest levels of therapeutic efficacy and patient safety.
This high-purity vasoprotective API is specifically vital in the following four sectors:
Primary treatment for diabetic retinopathy; thus helping to prevent capillary leakage and retinal damage.
Used in chronic venous insufficiency medications; consequently vital for reducing leg swelling and pain.
Key active ingredient for tablets and capsules; undoubtedly essential for high-quality drug formulations.
Utilized as a reference standard in microangiopathy studies; specifically supporting advanced medical R&D.
| Parameter | Standard Value |
|---|---|
| Product Name | Calcium Dobesilate 1-hydrate |
| Assay (Purity) | 99.0% – 101.0% |
| Appearance | White crystalline powder |
| CAS Number | 20123-80-2 |
⚠️ Safety & Handling: Calcium Dobesilate 1-hydrate is intended for pharmaceutical use and should only be handled by trained professionals. Therefore, store in tightly closed containers, protected from light and moisture to maintain chemical stability and potency.